Clinical Trial Update: Open-Label Adalimumab for Ulcerative Colitis Patients [Phase 1]

View source ↗

Summary

An open-label Phase 1 trial evaluated adalimumab in patients with ulcerative colitis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED